Skin and soft tissue infections in hospitalized and critically ill patients: A nationwide population-based study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Shen, Hsiu Nien ^a   Lu, Chin Li ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GANGRENE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NECROSIS; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; TAIWAN; CHILD; CRITICAL ILLNESS; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CRITICAL ILLNESS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; TAIWAN; YOUNG ADULT;

EID: 77953013794     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-151     Document Type: Article

References (29)

1. Rogers RL, Perkins J. Skin and soft tissue infections. Prim Care 2006, 33:697-710.
2. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA J. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008, 51:291-298. 10.1016/j.annemergmed.2007.12.004, 18222564.
3. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC, . Infectious Diseases Society of America Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373-1406. 10.1086/497143, 16231249, Infectious Diseases Society of America.
4. Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34(Suppl 1):S2-7. 10.1016/S0924-8579(09)70541-2, 19560670.
5. Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009, 15:1516-1518. 10.3201/eid1509.081228, 2819854, 19788830.
6. Vinh DC, Embil JM. Severe skin and soft tissue infections and associated critical illness. Curr Infect Dis Rep 2007, 9:415-421. 10.1007/s11908-007-0064-6, 17880853.
7. Napolitano LM. Severe soft tissue infections. Infect Dis Clin North Am 2009, 23:571-591. 10.1016/j.idc.2009.04.006, 19665084.
8. George SM, Harrison DA, Welch CA, Nolan KM, Friedmann PS. Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database. Crit Care 2008, 12(Suppl 1):S1. 10.1186/cc6141, 2607109, 19105799.
9. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
10. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004, 30:589-596. 10.1007/s00134-004-2157-0, 14963646.
11. Karlsson S, Varpula M, Ruokonen E, Pettilä V, Parviainen I, Ala-Kokko TI, Kolho E, Rintala EM. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med 2007, 33:435-443. 10.1007/s00134-006-0504-z, 17225161.
12. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, . EPIC II Group of Investigators International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329. 10.1001/jama.2009.1754, 19952319, EPIC II Group of Investigators.
13. Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 2007, 28:1290-1298. 10.1086/520743, 17926281.
14. Edelsberg J, Berger A, Weber DJ, Mallick R, Kuznik A, Oster G. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008, 29:160-169. 10.1086/526444, 18179372.
15. Zilberberg MD, Shorr AF, Micek ST, Hoban AP, Pham V, Doherty JA, Ramsey AM, Kollef MH. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol 2009, 30:1203-1210. 10.1086/648083, 19848604.
16. National Health Insurance Research Database. , http://w3.nhri.org.tw/nhird//en/index.htm
17. Cheng SH, Chen CC, Chang WL. Hospital response to a global budget program under universal health insurance in Taiwan. Health Policy 2009, 92:158-164. 10.1016/j.healthpol.2009.03.008, 19361879.
18. Lien HM, Chou SY, Liu JT. Hospital ownership and performance: evidence from stroke and cardiac treatment in Taiwan. J Health Econ 2008, 27:1208-1223. 10.1016/j.jhealeco.2008.03.002, 18486978.
19. Bureau of National Health Insurance National Health Insurance Annual Statistical Report. Taipei, Taiwan 1995-2004. Bureau of National Health Insurance.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
22. Adrie C, Francais A, Alvarez-Gonzalez A, Mounier R, Azoulay E, Zahar JR, Clec'h C, Goldgran-Toledano D, Hammer L, Descorps-Declere A, Jamali S, Timsit JF, . Outcomerea Study Group Model for predicting short-term mortality of severe sepsis. Crit Care 2009, 13:R72. 10.1186/cc7881, 2717433, 19454002, Outcomerea Study Group.
23. Carratalà J, Rosón B, Fernández-Sabé N, Shaw E, del Rio O, Rivera A, Gudiol F. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 2003, 22:151-157.
24. Redelings MD, Lee NE, Sorvillo F. Pressure ulcers: more lethal than we thought?. Adv Skin Wound Care 2005, 18:367-372. 10.1097/00129334-200509000-00010, 16160463.
25. Hsiao CT, Weng HH, Yuan YD, Chen CT, Chen IC. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med 2008, 26:170-175. 10.1016/j.ajem.2007.04.023, 18272096.
26. Bair MJ, Chi H, Wang WS, Hsiao YC, Chiang RA, Chang KY. Necrotizing fasciitis in southeast Taiwan: clinical features, microbiology, and prognosis. Int J Infect Dis 2009, 13:255-260. 10.1016/j.ijid.2008.04.015, 18922719.
27. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin 2008, 58:323-346. 10.3322/CA.2008.0015, 18971486.
28. Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg 2007, 193:385-388. 10.1016/j.amjsurg.2006.09.028, 17320540.
29. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 1997, 79:1635-1640. 10.1002/(SICI)1097-0142(19970415)79:8<1635::AID-CNCR30>3.0.CO;2-X, 9118051.